lodibet 111

NoneNEW YORK , Dec. 2, 2024 /PRNewswire/ -- Tannenbaum Helpern is pleased to announce that Anne-Mette Elkjær Andersen has joined the Firm as partner in the Firm's Corporate practice. Anne-Mette is a highly qualified corporate attorney focusing on cross border and U.S. mergers and acquisitions, international business transactions, and corporate transactions and corporate compliance for engineering & architecture firms. Her decades of experience include advising clients on strategic purchases and sales in many sectors, including engineering, architecture, and other licensed professional design professions; defense; software; renewable energy; oil and gas; technology; retail and manufacturing; service; aviation; and shipping and rail, among others. Anne-Mette comes to Tannenbaum Helpern from the New York office of Holland & Knight, where she counseled clients on international M&A, financing and securities, performed regulatory and licensing work for professional design corporations, and assisted startup and emerging growth companies enter the U.S. market. Her clients include U.S. and foreign established privately and publicly held corporations and emerging companies on stock and asset sales, joint ventures, and SPAC matters, among others. Her experience also includes advising foreign bank clients on loan and financing agreements involving U.S.-based subsidiaries of foreign clients. Anne-Mette's primary experience is with private strategic buyers and sellers, and she also has experience in public and private securities offerings and initial public offerings (IPOs), including simultaneous offerings both in the U.S. and internationally. Anne-Mette began her career in Denmark as a lawyer with the Danish Ministry of Justice. She also spent four years with the Danish law firm Reumert & Partners (now Kromann Reumert), primarily in the areas of general corporate law, M&A and insolvency law. While practicing in Denmark , Anne-Mette represented, among others, U.S., Canadian, and Danish corporations in M&A transactions and other corporate matters. Managing Partner Andrew W. Singer commented, "Anne-Mette will expand our Corporate and M&A practices, facilitate increased opportunities for our clients and increase our ability to pursue new client relationships, especially in overseas markets and the professional design professions. Welcome, Anne-Mette!" "Anne-Mette is a welcome addition to Tannenbaum Helpern . Her capabilities and international reach add to our existing platform and relationships, both in the U.S. and globally," said Drew Jaglom , Chair of Tannenbaum Helpern's Corporate practice. Regarding her arrival, Anne-Mette added, "It's my privilege to join Tannenbaum Helpern . I'm excited to be a part of such a talented team of attorneys, and a Firm that is focused on the future!" About Tannenbaum Helpern Since 1978, Tannenbaum Helpern Syracuse & Hirschtritt LLP has combined a powerful mix of insight, creativity, industry knowledge, legal talent and experience to successfully guide clients through periods of challenge and opportunity. Our mission is to deliver the highest quality legal services in a practical and efficient manner and to provide the judgment, common sense and legal acumen of well trained, business minded lawyers, all within a culture that fosters an inclusive and respectful workplace. Through our commitment to exceptional service and driven by a focus on results, Tannenbaum Helpern continues to earn the loyalty of our clients and a reputation for excellence. For more information, visit www.thsh.com . Jennifer Papantonio Chief Marketing & Business Development Officer papantonio@thsh.com 212.702.3147 View original content to download multimedia: https://www.prnewswire.com/news-releases/anne-mette-elkjaer-andersen-joins-tannenbaum-helpern-as-partner-in-the-firms-corporate-practice-group-302320136.html SOURCE Tannenbaum Helpern Syracuse & Hirschtritt LLPThe NHS in England is launching a world-first trial of a “gamechanging” artificial intelligence tool that can identify patients at risk of type 2 diabetes more than a decade before they develop the condition. More than 500 million people worldwide have type 2 diabetes , and finding new ways to spot people at risk before they develop the condition is a major global health priority. Estimates suggest 1 billion people will have type 2 diabetes by 2050. The condition is a leading cause of blindness, kidney failure, heart attacks, strokes and lower limb amputation. It is often linked to being overweight or inactive, or having a family history of type 2 diabetes, although not all those diagnosed are in those categories. Now doctors and scientists have developed a transformative AI tool that can predict those at risk of the condition as much as 13 years before it begins to develop. The technology analyses electrocardiogram (ECG) readings during routine heart scans. It can detect subtle changes too small to be noticed by the human eye that could raise the alarm early about a patient on the road to getting type 2 diabetes. It could enable early interventions and potentially help people avoid developing the condition altogether by, for example, making changes to their diet and lifestyle. The NHS will begin trialling the tool in 2025 at Imperial College healthcare NHS trust and Chelsea and Westminster hospital NHS foundation trust, and will be the first healthcare system in the world to do so, the Guardian has learned. Those involved in developing the technology, called the AI-ECG risk rstimation for diabetes mellitus (Aire-DM), hope it could be rolled out across the health service in England and in other countries within the next few years. “AI holds enormous potential to transform care that could lead to substantial improvements in health,” said Dr Libor Pastika, a clinical research training fellow at Imperial. “By using AI to unlock insights hidden within ECG data, Aire-DM could be revolutionary in identifying future risk of type 2 diabetes early on. “Offering a cheap, accessible, non-invasive way to predict type 2 diabetes risk early, Aire-DM could open up a new window of opportunity for more targeted, preventive care, helping people avoid the condition and its associated complications.” A team led by Dr Fu Siong Ng and Dr Arunashis Sau at Imperial developed the tool using 1.2m ECGs from hospital records. They then used data from the UK Biobank, which holds the genetic data and medical records of more than 500,000 participants, to validate the tool’s ability to detect subtle changes in ECGs. The tool maps tiny ECG patterns more common in those who will go on to develop type 2 diabetes in the future – and then looks for those same patterns in new ECGs. The telltale signs include variations in how the heart’s electrical signal travels, such as small changes in the timing, shape, or patterns of certain electrical waves. The tool can also identify longer electrical activation times or differences in the way the heart’s electrical signals reset. While these changes may seem minor, they reflect early effects of diabetes on the heart’s structure and function, well before symptoms appear. Tests have already shown the tool accurately predicts risk in people of various ages, genders, ethnicities and socioeconomic backgrounds about 70% of the time. When the AI predictions were combined with genetic and clinical information, such as age and blood pressure, accuracy improved further, providing an even clearer picture of risk, the researchers said. Prof Bryan Williams, the chief scientific and medical officer of the British Heart Foundation, a charity that helped fund the development of the tool, said: “This exciting research uses powerful artificial intelligence to analyse ECGs, revealing how AI can spot things that cannot usually be observed in routinely collected health data. “This kind of insight could be a gamechanger in predicting future risk of developing type 2 diabetes, years before the condition begins. “Type 2 diabetes is a rapidly growing health challenge that increases the risk of developing heart disease. However, with the right support it is possible for people to reduce their risk of developing the condition. “We look forward to seeing how this technology could be incorporated into clinical practice, providing an opportunity to intervene early to help reduce risk and even prevent type 2 diabetes and its associated complications, altogether.”I love nothing more than going to an infrared sauna and sweating it out — my mind immediately feels clearer, and my body feels better too. However, it can get expensive going to a bathhouse or a gym with a sauna on a weekly basis. That’s why this incredible world-first, accessible at-home portable infrared sauna is a game changer. Know the news with the 7NEWS app: Download today Vital+, a wellness brand known for its innovative products, has launched the infrared sauna which retails for $985 and offers a high-end wellness experience at a fraction of the cost of traditional saunas, which typically retail for more than $2000. It’s the perfect way to reap the benefits of infrared heat therapy without breaking the bank. VITAL+ was first established in March 2023 by Cameron Mehr and Tom Mansfield, who were inspired to start a wellness brand after discovering a significant gap in the market for at-home wellness products. The SaunaPod is designed for both indoor and covered outdoor spaces, providing flexibility and convenience for its users. Its compact pentagon design, just 1m by 1m, ensures it can fit comfortably in corners, making it ideal for small spaces. The sauna is also extremely easy to set up, with a simple 15-minute installation process, and can be packed down in just five minutes for easy storage. The SaunaPod can reach temperatures of up to 65C, offering a deeply relaxing and detoxifying experience. It operates using six infrared panels, which generate heat that penetrates deeply into the skin, promoting relaxation, improved circulation, and recovery. One of the standout features of the SaunaPod is its low electromagnetic field (EMF) levels, so the sauna ensures a safe and healthy environment for users. The sauna includes 660nm red light therapy, which is known to support skin rejuvenation and promote overall wellness. Additionally, the sauna features chromotherapy lights in four different colours, which can be used to enhance mood, energy, and relaxation. Plus, the SaunaPod is equipped with a heat-insulated cover that helps prevent mould and bacteria buildup. It also includes a quick-dry, machine-washable absorbent sweat mat for easy cleaning, after each use — you simply leave the door flap open to air out the sauna. The launch of the SaunaPod is perfectly timed for the holiday season, making it an ideal gift for wellness enthusiasts or anyone looking to start the new year with a focus on health and recovery. Its portable, affordable, and space-saving design makes it the perfect solution for those seeking a high-quality sauna experience in the comfort of their own home. To purchase the Infrared sauna, head to the VITAL+ website here.

Colts defense picks up the pace as offense continues searching for answers to red zone woesQB Josh Allen and coach Sean McDermott deserve credit in Bills latest AFC East-clinching season